Search

For a decade, Abt Global has worked to understand the impact and prevent the spread of the disease in the United States and abroad, including in low- and middle-income countries.

Our toxicologists design, implement, conduct and manage a wide range of laboratory and field-based bioassays, investigations and other tests to fill key data gaps and increase our understanding of the adverse effects of chemicals, mixtures, and other stressors on numerous organisms, including bacteria, algae, invertebrates, fish, reptiles, birds, and mammals.

This feasibility study will help BJS assess whether to try to gather reliable national data on misdemeanor charges filed in state, county, and city courts.

Our work has helped address the supply of and demand for illegal drugs and the misuse of legal substances for federal, state and local agencies, as well as other key stakeholders.

The majority of American adults take dietary supplements, and the market for these products continues to grow. In the U.S., dietary supplements are regulated by the Food and Drug Administration (FDA) as food, not as drugs, and do not require approval or…

Tests in Cote d’Ivoire show vector susceptibility to ITNs treated with chlorfenapyr to be much higher than for pyrethroids alone or with piperonyl butoxide.

Abt Global’s proven health systems solutions — spanning financing, efficiency, resilience, private sector engagement, and digital integration — equip partner governments to sustain health gains and transition donor-funded programs to full country ownership.